Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion

BACKGROUND: Fibroblast growth factor 2 (FGFR2) amplification, occurring in ~2–9% of gastric cancers (GC), is associated with poor overall survival. RESULTS: RNA sequencing identified a novel FGFR2-ACSL5 fusion in the resistant tumor that was absent from the matched pre-treatment tumor. The FGFR2-amp...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Kim, Sun Young, Ahn, Taejin, Bang, Heejin, Ham, Jun Soo, Kim, Jusun, Kim, Seung Tae, Jang, Jiryeon, Shim, Moonhee, Kang, So Young, Park, Se Hoon, Min, Byung Hoon, Lee, Hyuk, Kang, Won Ki, Kim, Kyoung-Mee, Park, Woongyang, Lee, Jeeyun
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2017
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5362463/
https://ncbi.nlm.nih.gov/pubmed/28122360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14788
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars